These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Postoperative recurrence of hepatocellular carcinoma: results of transcatheter arterial chemoembolization. Park JH, Han JK, Chung JW, Han MC, Kim ST. Cardiovasc Intervent Radiol; 1993; 16(1):21-4. PubMed ID: 8382109 [Abstract] [Full Text] [Related]
6. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter arterial chemoembolization. Okuda M, Miyayama S, Yamashiro M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Sanada T, Kosaka S, Toya D, Matsui O. Cardiovasc Intervent Radiol; 2010 Jun; 33(3):619-23. PubMed ID: 19609604 [Abstract] [Full Text] [Related]
7. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study. Wang C, Liao Y, Qiu J, Yuan Y, Zhang Y, Li K, Zou R, Wang Y, Zuo D, He W, Zheng Y, Li B, Yuan Y. J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005 [Abstract] [Full Text] [Related]
9. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M. Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241 [Abstract] [Full Text] [Related]
10. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, Honda S, Koshiishi T, Fujimoto T. Cardiovasc Intervent Radiol; 2007 Aug; 30(4):696-704. PubMed ID: 17497071 [Abstract] [Full Text] [Related]
15. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma. Endo K, Kuroda H, Oikawa T, Okada Y, Fujiwara Y, Abe T, Sato H, Sawara K, Takikawa Y. Scand J Gastroenterol; 2018 Dec; 53(12):1575-1583. PubMed ID: 30577723 [Abstract] [Full Text] [Related]
16. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection. Song Q, Ren W, Fan L, Zhao M, Mao L, Jiang S, Zhao C, Cui Y. Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995 [Abstract] [Full Text] [Related]